For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Researchers led by the University of Oxford have won a major grant from Diabetes UK to set up the UK's first registry of people at risk of developing type 1 diabetes (T1D) after testing positive for ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...

That mixed feeling of dread and hope when standing on the bathroom scales is a familiar companion, a silent negotiation with ...